Publication & Citation Trends
Most Cited Works
Publications
237 total
Remestemcel-L-Rknd (Ryoncil) Improves Survival after Failure of Second-Line Treatment for SR-aGVHD
Cited by 0
Semantic Scholar
Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study PDF
Cited by 297
OpenAlex
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma PDF
Cited by 502
OpenAlex
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma PDF
Cited by 1,765
OpenAlex
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
Cited by 2,192
OpenAlex
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma PDF
Cited by 5,759
OpenAlex
Research Topics
Hematopoietic Stem Cell Transplantation
(105)
CAR-T cell therapy research
(33)
Systemic Sclerosis and Related Diseases
(30)
Lymphoma Diagnosis and Treatment
(23)
Chronic Lymphocytic Leukemia Research
(23)
Frequent Co-Authors
Affiliations
Rutgers, The State University of New Jersey
Dartmouth College
City Of Hope National Medical Center
National Marrow Donor Program
United States Department of Veterans Affairs